Literature DB >> 11717137

Resumption of meiosis induced by meiosis-activating sterol has a different signal transduction pathway than spontaneous resumption of meiosis in denuded mouse oocytes cultured in vitro.

I Faerge1, B Terry, J Kalous, P Wahl, M Lessl, J L Ottesen, P Hyttel, C Grøndahl.   

Abstract

The sterol 4,4-dimethyl-5-cholesta-8,14,24-trien-3-ol (follicular fluid meiosis-activating sterol [FF-MAS]) isolated from human follicular fluid induces resumption of meiosis in mouse oocytes cultured in vitro. The purpose of this study was to examine the hypothesis that differential signal transduction mechanisms exist for FF-MAS-induced and spontaneous in vitro resumption of meiosis in mouse oocytes. Mouse oocytes were dissected from ovaries originating from mice primed with FSH 48 h before oocyte collection. Mechanically denuded germinal vesicle (GV) oocytes were in vitro matured in medium supplemented with hypoxanthine and FF-MAS or allowed to mature spontaneously; both groups were exposed to individual compounds known to inhibit specific targets in the cell. After 20-22 h of in vitro maturation, resumption of meiosis was assessed as the frequency of oocytes in GV breakdown (GVBD) stage. Pertussis toxin (2.5 microg/ml) did not influence resumption of meiosis in either group. Dibutyryl cyclic GMP (320 microM) inhibited FF-MAS-induced GVBD, but not spontaneous GVBD, whereas the subtype 5 phosphodiesterase-inhibitor zaprinast (50 microM) inhibited GVBD in both groups. Microinjection of the catalytic subunit of cAMP-dependent protein kinase into oocytes inhibited spontaneous GVBD, but not FF-MAS-induced GVBD. An inhibitor of cytoplasmic polyadenylation, cordycepin (80 microM), inhibited or retarded spontaneous GVBD to a further extent than it did FF-MAS-induced GVBD. Spontaneous GVBD was more sensitive to the histone H1 kinase-inhibitor olomoucine (250 microM) than was FF-MAS-induced GVBD. Addition of the mitogen-activated protein kinase (MAPK)-inhibitor PD 98059 (50 microM), phospholipase C-inhibitor U-73122 (10 microM), p21(ras)-inhibitor lovastatine (250 microM), and the src-like kinase inhibitor PP2 (20 microg/ml) inhibited FF-MAS-induced GVBD, but not spontaneous GVBD. Both MAPKs, extracellular regulated kinase (ERK) 1 and ERK2, were phosphorylated under FF-MAS-induced meiotic resumption, in contrast to spontaneous meiotic resumption, in which ERK1 and ERK2 phosphorylation occurred 2 h after GVBD. In the present study, we show that FF-MAS acts through an MAPK-dependent pathway, and we suggest that src-like kinase, p21(ras), and phosphoinositide signaling lie upstream of MAPK in the FF-MAS-activated signaling pathway. Clearly, striking pathway differences are present between spontaneous versus FF-MAS-induced meiotic resumption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717137     DOI: 10.1095/biolreprod65.6.1751

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  10 in total

1.  Meiotic resumption in response to luteinizing hormone is independent of a Gi family G protein or calcium in the mouse oocyte.

Authors:  Lisa M Mehlmann; Rebecca R Kalinowski; Lavinia F Ross; Albert F Parlow; Erik L Hewlett; Laurinda A Jaffe
Journal:  Dev Biol       Date:  2006-08-05       Impact factor: 3.582

Review 2.  Regulation of the G2/M transition in rodent oocytes.

Authors:  Stephen M Downs
Journal:  Mol Reprod Dev       Date:  2010-07       Impact factor: 2.609

Review 3.  Oocyte maturation: the coming of age of a germ cell.

Authors:  Michelle Jamnongjit; Stephen R Hammes
Journal:  Semin Reprod Med       Date:  2005-08       Impact factor: 1.303

4.  Short-term hypertonic exposure enhances in vitro follicle growth and meiotic competence of enclosed oocytes while modestly affecting mRNA expression of aquaporin and steroidogenic genes in the domestic cat model.

Authors:  N Songsasen; C Thongkittidilok; K Yamamizu; D E Wildt; P Comizzoli
Journal:  Theriogenology       Date:  2016-12-09       Impact factor: 2.740

5.  Paracrine factors from cumulus-enclosed oocytes ensure the successful maturation and fertilization in vitro of denuded oocytes in the cat model.

Authors:  Natasha M Godard; Budhan S Pukazhenthi; David E Wildt; Pierre Comizzoli
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

6.  Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.

Authors:  Anna Sukhanova; Andrey Gorin; Ilya G Serebriiskii; Linara Gabitova; Hui Zheng; Diana Restifo; Brian L Egleston; David Cunningham; Tetyana Bagnyukova; Hanqing Liu; Anna Nikonova; Gregory P Adams; Yan Zhou; Dong-Hua Yang; Ranee Mehra; Barbara Burtness; Kathy Q Cai; Andres Klein-Szanto; Lisa E Kratz; Richard I Kelley; Louis M Weiner; Gail E Herman; Erica A Golemis; Igor Astsaturov
Journal:  Cancer Discov       Date:  2012-11-02       Impact factor: 39.397

7.  Reducing CYP51 inhibits follicle-stimulating hormone induced resumption of mouse oocyte meiosis in vitro.

Authors:  Chao Wang; Baoshan Xu; Bo Zhou; Cheng Zhang; Jie Yang; Hong Ouyang; Gang Ning; Meijia Zhang; Jianzhong Shen; Guoliang Xia
Journal:  J Lipid Res       Date:  2009-05-11       Impact factor: 5.922

Review 8.  A Systematic Review of the Biological Effects of Cordycepin.

Authors:  Masar Radhi; Sadaf Ashraf; Steven Lawrence; Asta Arendt Tranholm; Peter Arthur David Wellham; Abdul Hafeez; Ammar Sabah Khamis; Robert Thomas; Daniel McWilliams; Cornelia Huiberdina de Moor
Journal:  Molecules       Date:  2021-09-28       Impact factor: 4.411

Review 9.  Post-Translational Modifications in Oocyte Maturation and Embryo Development.

Authors:  Yu Wu; Mo Li; Mo Yang
Journal:  Front Cell Dev Biol       Date:  2021-06-02

10.  The proto-oncogene c-src is involved in primordial follicle activation through the PI3K, PKC and MAPK signaling pathways.

Authors:  Xiao-Yu Du; Jian Huang; Liang-Quan Xu; Dan-Feng Tang; Lei Wu; Li-Xia Zhang; Xiao-Ling Pan; Wei-Yun Chen; Li-Ping Zheng; Yue-Hui Zheng
Journal:  Reprod Biol Endocrinol       Date:  2012-08-20       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.